PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026The Journal of Rheumatology0 citations

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study

JRJohn D. ReveilleADAtul DeodharOregon Health & Science UniversityPCPaul H. CaldronNorthwestern University

Key Points

  • The aim is to assess the safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis over one year.
  • Evaluated the impact of golimumab on ankylosing spondylitis symptoms.
  • Used the Bath Ankylosing Spondylitis Metrology Index (BASMI).
  • Applied the University of California San Francisco (UCSF) Enthesitis Index.
  • Administered corrections to data errors related to BASMI and Enthesitis Index.
  • Findings indicated potential positive effects on the safety and efficacy profile.

Abstract

J Rheumatol 2019; doi: 10.3899/jrheum.180718 Recently, the sponsor became aware of data errors related to Bath Ankylosing Spondylitis Metrology Index (BASMI) and the University of California San Francisco (UCSF) Enthesitis Index. The ensuing tabular and in-text corrections are provided hereinafter.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Reveille et al. (2026) studied this question.

synapsesocial.com/papers/69cf5f005a333a821460dc11https://doi.org/10.3899/jrheum.180718.c1
Ask AI
Helpful
Bookmark
Share
View Full Paper